Jovanovic et al. have documented that women with GDM who received a rapid-acting insulin analogue (insulin lispro) in a 6-week study had significantly lower postprandial increases in plasma C-peptide (and hence in endogenous insulin secretion) than those who injected regular human insulin [16]. This evidence concerns the gene INS and gestational diabetes.